19-12649174-C-G
Variant summary
Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PS1_Very_StrongPM2PP3_StrongPP5_Very_Strong
The NM_000528.4(MAN2B1):c.2398G>C(p.Gly800Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G800W) has been classified as Uncertain significance.
Frequency
Consequence
NM_000528.4 missense
Scores
Clinical Significance
Conservation
Publications
- alpha-mannosidosisInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Myriad Women’s Health, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 22 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAN2B1 | NM_000528.4 | c.2398G>C | p.Gly800Arg | missense_variant | Exon 20 of 24 | ENST00000456935.7 | NP_000519.2 | |
| MAN2B1 | NM_001440570.1 | c.2401G>C | p.Gly801Arg | missense_variant | Exon 20 of 24 | NP_001427499.1 | ||
| MAN2B1 | NM_001173498.2 | c.2395G>C | p.Gly799Arg | missense_variant | Exon 20 of 24 | NP_001166969.1 | ||
| MAN2B1 | XM_047438841.1 | c.1297G>C | p.Gly433Arg | missense_variant | Exon 13 of 17 | XP_047294797.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MAN2B1 | ENST00000456935.7 | c.2398G>C | p.Gly800Arg | missense_variant | Exon 20 of 24 | 1 | NM_000528.4 | ENSP00000395473.2 | ||
| MAN2B1 | ENST00000221363.9 | c.2395G>C | p.Gly799Arg | missense_variant | Exon 20 of 24 | 1 | ENSP00000221363.4 | |||
| MAN2B1 | ENST00000466794.5 | n.2988G>C | non_coding_transcript_exon_variant | Exon 18 of 22 | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251404 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460498Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726558 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Deficiency of alpha-mannosidase Pathogenic:4Uncertain:1
- -
- -
Variant summary: MAN2B1 c.2398G>C (p.Gly800Arg) results in a non-conservative amino acid change located in the glycosyl hydrolase family 38, C-terminal domain (IPR011682) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251404 control chromosomes (gnomAD). c.2398G>C has been reported in the literature in the compound heterozygous state together with a truncating variant in an individual affected with Alpha-Mannosidosis (Riise Stensland_2012, Borgwardt_2015). These data do not allow any conclusion about variant significance. Functional studies have found that the variant has impaired transport to lysosomes, producing a protein that is not intracellularly processed like the WT protein, and it results in <20% activity of the WT enzyme (e.g. Kuokkanen_2011, Riise Stensland_2012, Borgwardt_2015). Additionally, another variant affecting the same amino acid (c.2398G>T, p.G800W) has also been reported in association with Alpha-Mannosidosis in the HGMD database, suggesting Gly800 may be important for protein function. The following publications have been ascertained in the context of this evaluation (PMID: 26048034, 21505070, 22161967). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at